CVS Health (CVS) closed at $69.39 in the latest trading session, marking a +1.15% move from the prior day.
Elevance Health offered skittish investors another signal that health insurers aren’t getting hit with higher-than-expected costs, reporting results that beat Wall Street expectations. Elevance stock rose over 5% early Thursday, on track for its highest close since December 2022. The earnings may help sustain a rally that began Tuesday, when UnitedHealth released results that also came in above analysts’ projections and said healthcare expenses were running at expected rates.
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.